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SUMMARY
Neural stem/progenitor cells (NSPCs) generate new neurons throughout life in distinct areas of the adult mammalian brain. Besides
classical transgenesis-based approaches, retrovirus-mediated genetic manipulation is frequently used to study mechanisms that regulate
neurogenesis in the nervous system. Here, we show that fusion of a tamoxifen-regulatable estrogen receptor (ERT2) motif to transcription
factors (i.e., ASCL1 andNEUROD1) enables temporal control of transgene expression in adultmouseNSPCs in vitro and in vivo. Thus, the
approach described here represents a versatile strategy for regulating gene expression to study gene function in dividing cells and their
progeny.
INTRODUCTION
Neural stem/progenitor cells (NSPCs) generate new neu-
rons throughout life in distinct areas of the adult mamma-
lian brain, including the subventricular zone (SVZ) lining
the lateral ventricles from which newborn cells migrate
toward the olfactory bulb and the hippocampal dentate
gyrus (DG) (Zhao et al., 2008). Due to the relative sparse-
ness of NSPCs and their progeny in relation to pre-existing
neural structures, there is a need to selectively manipulate
gene activity in NSPCs and their progeny to address their
functional significance during the course of development
from a dividing NSPC to a fully mature and synaptically
integrated neuron (Dhaliwal and Lagace, 2011).
One approach to test the functional significance of
genes/pathways is to use transgenic mice carrying floxed
alleles of genes of interest, together with Tamoxifen
(TAM)-regulatable Cre-recombinase controlled by NSPC-
or immature neuron-selective promoters, to genetically re-
combine and delete genes (Ihrie et al., 2011; Sahay et al.,
2011). In addition, retroviral vectors derived fromMoloney
murine leukemia viruses have proved to be an important
tool to visualize newborn cells through the expression of
fluorescent proteins, as well as to manipulate gene expres-
sion using both gain- and loss-of-function strategies (Ge
et al., 2006; van Praag et al., 2002). The use of retroviruses
has the advantage that it is highly selective for dividing
cells (i.e., neurogenic cells when injected into the SVZ or
DG) and is a very fast method because extensive breeding
to obtain correct genotypes, as is the case for classical trans-
genesis, is not required (Zhao and Gage, 2008).
However, retroviral vectors do not target bona fideNSPCs
that are largely quiescent but integrate into highly prolifer-
ative neural progenitors, which restrict virus-mediated
genetic manipulations to later steps of neurogenesis.
Furthermore, current vectors do not allow inducible or
temporally controlled expression of the virus-driven trans-
gene. Temporal control of transgene expression would be
advantageous for studying gene function during distinct
steps in the course of neuronal development. This is espe-
cially true for transcription factors (TFs) that may exert
stage-specific functions depending on the age of a given
newborn cell (Iwano et al., 2012). We reasoned that fusion
of a TAM-regulatable estrogen receptor (ERT2) motif (Indra
et al., 1999; Jiang et al., 2010) to expression constructs of
TFs involved in neurogenesis would enable TAM-induced
transgene expression, allowing for temporal control of
virus-mediated gene expression (Figures 1A and 1B; Supple-
mental Experimental Procedures available online).
RESULTS
It was previously shown that Ascl1 overexpression in
cultured adult NSPCs results in robust neuronal differenti-
ation (Jessberger et al., 2008). To analyze whether fusion of
Ascl1 to the ERT2 motif leads to functional ASCL1 expres-
sion upon TAM treatment, we transduced NSPCs isolated
from adult mice with Ascl1-ERT2-IRES-GFP (hereafter called
Ascl1-ERT2)-expressing retroviruses in vitro. To induce
translocation of the ASCL1-ERT2 fusion protein, we treated
the cells with hydroxy-TAM (OH-TAM) and analyzed them
7 days after the onset of differentiation. Whereas Ascl1-
ERT2-expressing cells cultured without OH-TAM did not
show any difference in their rate of neuronal differentia-
tion compared with cells transduced with a control
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Figure 1. Temporal Control of Retrovirus-Mediated Ascl1-ERT2 Activity In Vitro
(A) Two-step PCR cloning strategy to fuse an ERT2 motif to TFs expressed from a retroviral vector. Upon binding of TAM to the ERT2 motif,
the TF translocates to the nucleus and regulates target gene transcription.
(B) Western blot analysis reveals the fusion of an ERT2 motif to ASCL1, using an ASCL1 antibody to visualize the WT and fusion proteins.
(C) Differentiation of adult NSPCs transduced with Ascl1-ERT2-expressing virus (green) without OH-TAM yields only a minority of neuronally
differentiated cells expressing MAP2AB (red), whereas most cells differentiate into glial cells expressing GFAP (blue). Right bars show
quantifications.
(D) Exposure of Ascl1-ERT2-expressing cells (green) to OH-TAM for 4 days leads to the dramatic induction of neuronal differentiation as
measured with MAP2AB (red) and a reduction in GFAP-positive cells (blue). Right bars show quantifications. TAM: 8.04% ± 1.53%
neurons; +TAM: 91.58% ± 2.14% neurons; *p < 0.001; n = 3, biological replicates.
(E) NSPCs transduced with Ascl1-ERT2-expressing virus (green) can be properly propagated as monolayers expressing SOX2 (red, left panels)
or floating neurospheres in the absence of OH-TAM (right panel), indicating the tight control of virus-mediated gene expression with TAM.
Images were taken 10 days after viral transduction.
Error bars represent mean ± SEM. Scale bars represent 40 mm (C, D, and E, left panel) and 100 mm (E, right panel). Nuclei were stained with
DAPI (gray).
See also Figures S1 and S3.
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retrovirus (expressing IRES-GFP), treatment of Ascl1-ERT2-
expressing cells with OH-TAM resulted in a dramatic
increase in neuronal differentiation (Figures 1C, 1D, S1A,
and S1B). These findings suggest that OH-TAM treatment
resulted in the robust and efficient transcriptional activa-
tion of ASCL1 target genes to induce neuronal differentia-
tion in vitro. To confirm that this approach is applicable
to other TFs and not restricted to ASCL1, we fused the basic
helix-loop-helix TF NEUROD1 to an ERT2motif (Figure 2D)
and infected NSPC cultures with NeuroD1-ERT2-IRES-GFP-
expressing retroviruses. As before, we observed the almost
complete neuronal differentiation of NSPCs upon OH-
TAM treatment (Figures 2A–2C). This finding is consistent
with the induction of NEUROD1 transcriptional activity, as
it was previously shown that NEUROD1 overexpression
promotes neuronal differentiation of NSPCs (Gao et al.,
2009). Furthermore, we were able to confirm that the sub-
cellular localization of ASCL1-ERT2 and NEUROD1-ERT2
was indeed controlled by OH-TAM-dependent transloca-
tion of the fusion proteins from the cytoplasm to the
nucleus of transduced NSPCs (Figures S2A and S2B).
A current limitation in studying neuronal differentiation
using cultured NSPCs is that the rate of neuronal differen-
tiation of adult NSPCs is rather incomplete: when standard
protocols of growth-factor withdrawal are used, only 8%–
30% of NSPC progeny differentiate toward the neuronal
lineage (as measured by MAP2AB or TUJ1 expression),
whereas the majority of NSPC-derived cells differentiate
into glial cells (Babu et al., 2007; Seaberg et al., 2005).
Therefore, an inducible system that allows complete and
reproducible conversion of undifferentiated NSPCs into
neurons would represent a major advantage compared
with existing protocols. Thus, we next analyzed whether
NSPCs expressing ASCL1-ERT2 fusion proteins can be prop-
agated as proliferating neurospheres or monolayer cultures
when OH-TAM is absent, and be committed to neuronal
differentiation when OH-TAM is added. NSPCs were trans-
duced with Ascl1-ERT2 expressing retroviruses and cultured
for several weeks thereafter. In the absence of OH-TAM,
Ascl1-ERT2-expressing NSPCs continued to express the
NSPC marker SOX2, showed very similar rates of prolifera-
tion compared with control cells labeled with a GFP-
expressing retrovirus, and could be repeatedly passaged
as neurospheres (Figure 1E). Strikingly, the pulse of OH-
TAM induced the near-complete differentiation of Ascl1-
ERT2-expressing NSPCs into neurons (as measured by
MAP2AB labeling), indicating that controllable transgene
expression is tightly regulated and that transient induction
Figure 2. Inducible NeuroD1 Expression
Using TAM in Cultured NSPCs
(A) Differentiation of adult NSPCs trans-
duced with NeuroD1-ERT2-expressing virus
(green) without OH-TAM does not alter
neural differentiation as measured by
MAP2AB expression (red) for neuronal cells
and GFAP (blue) for glial cells.
(B) Cells transduced with NeuroD1-ERT2-
expressing virus almost exclusively differ-
entiate into neuronal cells expressing
MAP2AB (red) upon OH-TAM exposure.
(C) Quantification of neuronal differ-
entiation of NeuroD1-ERT2-expressing cells
in vitro with (right graphs) and without
OH-TAM exposure (left graphs), indicating
the robust control of TAM-regulated
gene expression. TAM: 8.08% ± 1.85%
neurons; +TAM: 93.59% ± 1.46% neurons;
*p < 0.001; n = 3, biological replicates.
(D) Western blot analysis reveals the fusion
of an ERT2 motif to a NeuroD1 expression
construct, using NEUROD1 antibody to
visualize the WT and fusion proteins.
Error bars represent mean ± SEM. Scale bars
represent 40 mm. Nuclei were stained with
DAPI (gray).
See also Figure S2.
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of Ascl1 is sufficient to promote neuronal differentia-
tion of culturedNSPCs. Therefore, after an initial induction
of ASCL1 transcriptional activity to trigger neuronal
differentiation, NSPCs differentiate under normal condi-
tions, as ASCL1-ERT2 is no longer active in the absence of
OH-TAM. Again, similar results were obtained when we
used NeuroD1-ERT2-expressing cells, further supporting
the feasibility of this inducible approach (data not
shown). To analyze the dynamics of Ascl1-ERT2-mediated
neuronal differentiation in greater detail, we first shortened
the time of OH-TAM treatment from 4 days to 2 days,
which also resulted in a strong increase in neuronal
differentiation (Figures S3A and S3B). In addition, we per-
formed luciferase assays using a basic helix-loop-helix
(bHLH) reporter construct as described previously (Castro
et al., 2006) to monitor ASCL1 transcriptional activity.
We measured a rapid induction of luciferase activity
upon OH-TAM treatment (Figure S3C), further confirming
the efficacy and tight temporal control of the ERT2-based
system.
Next, we sought to analyze whether TAM-inducible
Ascl1-ERT2 gene expression is sufficient to convert NSPC-
derived astrocytes toward a neuronal lineage. As shown
above, the majority of NSPCs differentiated into glial
fibrillary acidic protein (GFAP)-expressing astrocytes after
growth-factor withdrawal (Figure 1C). To test whether
these astroglia could be converted toward a neuronal fate
(Heinrich et al., 2010) using the Ascl1-ERT2 system, NSPCs
were differentiated for 7 days, exposed to OH-TAM for
4 days, and then analyzed for neuronal differentiation.
Strikingly, treatment of differentiated cells with OH-TAM
led to a robust increase in MAP2AB-expressing neurons
(Figures 3A and 3B). These findings indicate that ERT2-
based control of proneural gene expression is effective for
driving neuronal differentiation in nondividing (i.e., ethy-
nyl-deoxy-uridine [EdU] negative), differentiated astroglial
cells (Figures 3A–3C).
After showing that fusion of TFs to an ERT2 motif is suit-
able for controlling gene expression in vitro, we next tested
the system in vivowithin the neurogenic niche of the adult
hippocampus. We previously showed that retrovirus-
mediated ASCL1 overexpression within the adult DG redi-
rects the progeny of NSPCs away from a neuronal fate and
toward the oligodendrocytic lineage (Jessberger et al.,
2008). Therefore, NSPCs respond differently to ASCL1
overexpression in vivo (i.e., oligodendrocytic differentia-
tion) and in vitro (i.e., neuronal differentiation). At this
time, it remains unclear whether this is due to intrinsic dif-
ferences or niche-derived cues that are responsible for the
context-dependent behavior of adult hippocampal NSPCs
(Jessberger et al., 2008). Be that as it may, we made use
of this robust cellular phenotype and tested whether
the system of retrovirus-mediated, TAM-controlled gene
expression also functions in vivo. Animals were injected
with Ascl1-ERT2-expressing retroviruses and treated for 5
consecutive days with i.p. TAM injections (to switch the
transgene on). Notably, 3 weeks after viral injection, the
vast majority of newborn cells in the TAM-treatedmice dis-
played an oligodendrocytic phenotype and expressed
OLIG2, NG2, and SOX10 (Figures 4B–4D). These results
phenocopied previous results obtained using noninducible
retroviruses with constitutively active chicken beta-actin
promoter driving Ascl1, although the phenotypic switch
was not as complete (Ascl1-ERT2: +TAM 73.96% ± 6.72%
oligodendrocytes, constitutively active Ascl1 overex-
pression: 87.52% ± 2.08% oligodendrocytes, resulting in
an efficiency of 84.50% to redirect newborn cells toward
the oligodendrocytic lineage using the ERT2-based
approach compared with constitutively active Ascl1 over-
expression; see also Jessberger et al., 2008). These data
clearly indicate the functional induction of ASCL1 target
gene expression using the Ascl1-ERT2 system within the
adult hippocampus. In striking contrast, we observed
almost no fate change of newborn cells toward the
oligodendrocytic lineage in mice that were injected with
Ascl1-ERT2-expressing retroviruses but had not received
TAM injections (Figures 4A and 4C). Notably, delayed onset
of TAM administration, starting 4 weeks after stereotactic
injections of Ascl1-ERT2-expressing viruses, did not affect
the fate-choice decisions of newborn cells in the adult
DG, in contrast to the in vitro situation where glial cells
could be redirected toward a neuronal fate upon TAM-
induced ASCL1-ERT2 activation (Figures 3A–3C and
S4B–S4E). In summary, these data further underline the
tightness of the ERT2-based system to drive gene expression
in newborn cells.
DISCUSSION
We have described an approach that achieves inducible,
retrovirus-mediated gene expression by using the coding
sequence of TFs fused to an ERT2 motif. Fusion of the
ERT2 motif to two TFs that regulate fate-choice decisions
in the course of adult neurogenesis (i.e., ASCL1 and
NEUROD1) allowed tight temporal control of functional
gene expression in cultured NSPCs as well as within a
neurogenic niche of the adult brain.
The approach described here extends the range of appli-
cations for retrovirus-mediated gene manipulation. This
highly selective and extremely fast strategy to test gene
function in the context of mammalian neurogenesis can
be combined with an ERT2-mediated system for temporal
control of gene expression, allowing one to switch gene
expression on (and off) with the use of TAM. Thus, with
this simple two-step cloning protocol, it is now possible
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to test the function of genes in distinct stages or for
different durations during neural development both
in vitro and in vivo.
Using this inducible system, we were able to
dramatically increase the neuronal differentiation of
NSPCs, with >90% of NSPC-derived cells differentiating
into neurons in vitro, which is similar to the rate of
neuronal differentiation observed within the hippo-
campal niche. Thus, the approach described here over-
comes the problems associated with mixed neuronal
and glial cultures. For example, proteomics or meta-
bolomics studies comparing NSPCs with their neu-
ronally differentiated progeny, which require large
amounts of cells, can now be performed with reproducible
Figure 3. TAM Treatment Converts Astroglia toward a Neuronal Fate in Differentiated Ascl1-ERT2-Expressing NSPCs
(A) Ascl1-ERT2-expressing cells were differentiated for 7 days in the absence of OH-TAM and mainly gave rise to MAP2AB-negative
differentiated astroglia. Right bars show quantifications. Notably, virtually all of the NSPCs (>99.5%) are negative for EdU (blue),
indicating that the cells have exited the cell cycle and become postmitotic. The arrow points toward one of the rare EdU-labeled cells
(n = 3, biological replicates).
(B) The vast majority of Ascl1-ERT2-expressing cells (green) continue to differentiate into glial cells expressing GFAP (blue) and are
negative for MAP2AB (red) in the absence of OH-TAM. In striking contrast, OH-TAM exposure 7 days after initiation of differentiation
results in a robust increase in MAP2AB-expressing, neuronally differentiated cells, suggesting that OH-TAM-induced ASCL1 activity is also
sufficient to drive neuronal differentiation in NSPC-derived cells that have adopted an astroglial fate. Right bars show
quantifications. TAM: 15.24% ± 4.84% neurons; +TAM: 57.80% ± 3.07% neurons; *p < 0.001; n = 3, biological replicates.
(C) Experimental design of delayed OH-TAM treatment.
Error bars represent mean ± SEM. Scale bars represent 40 mm. Nuclei were stained with DAPI (gray).
See also Figure S3.
118 Stem Cell Reports j Vol. 1 j 114–122 j August 6, 2013 j ª2013 The Authors
Stem Cell Reports
Inducible Retroviral Gene Expression in NSPCs
and almost pure neuronal populations. We were also able
to use inducible ASCL1 overexpression to convert NSPC-
derived astrocytes into neurons. Furthermore, there is
increasing evidence that newborn neurons of different
ages have specific functions within the hippocampus;
therefore, the newly developed inducible strategy may
help improve our understanding of the molecular mecha-
nisms that regulate distinct steps of newborn neuron
maturation.
Clearly, the approach described here is not limited to
studying genes in the context of adult neurogenesis. A large
number of experiments aiming to manipulate TFs will
benefit from an ERT2-based temporal control of gene
expression (in retroviral or plasmid DNA format) in both
adult and embryonic tissues (e.g., using in utero electropo-
ration of plasmids encoding for TF-ERT2-fusion proteins).
In addition, the approach described here will be useful for
studying the temporal requirements of selected TFs in the
Figure 4. Inducible and Controllable Gene Expression in Newborn Cells within the Adult Hippocampus
(A) Injection of Ascl1-ERT2-expressing retroviruses (green) into the adult DG without TAM treatment leads to the labeling of newborn
granule cells (NEUN positive, red) 3 weeks after viral injection, similar to transduction of dividing cells with a control virus (data not
shown), indicating that ASCL1 expression is not active without TAM-induced nuclear translocation.
(B) TAM treatment for 5 days after injection of Ascl1-ERT2-expressing retroviruses induces oligodendrocytic differentiation (OLIG2 pos-
itive, red) of transduced cells within the adult DG, indicating the tight temporal control of gene expression in adult-born cells.
(C) Quantifications of the phenotypic shift induced by TAM-mediated activation of ASCL1 transcriptional activation in Ascl1-ERT2-
expressing cells. TAM: 13.98% ± 1.92% oligodendrocytes; +TAM: 73.96% ± 6.72% oligodendrocytes; *p < 0.001; n = 4, biological
replicates.
(D) TAM-induced gene expression in Ascl1-ERT2-transduced cells (green) results in expression of NG2 (red, upper panels) and SOX10
(red, lower panels), indicating a fate switch from the neuronal toward the oligodendrocytic lineage.
Error bars represent mean ± SEM. Scale bar represents 20 mm. Nuclei were stained with DAPI (blue).
See also Figure S4.
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context of cellular reprogramming of somatic cells toward
distinct lineages or pluripotency (Takahashi and Yama-
naka, 2006; Vierbuchen et al., 2010).
EXPERIMENTAL PROCEDURES
Cloning
The complementary DNA (cDNA) sequence of Ascl1 and NeuroD1
TFs was fused to the ERT2 motif by fusion PCR as described in
Figure 1A and Supplemental Experimental Procedures. TF and
ERT2 cDNA fragments were PCR amplified individually (PCR 1:
primers P1 and P2, TF cDNA as template; PCR 2: primers P3 and
P4, ERT2 cDNA as template). The PCR products were then used as
templates for the fusion PCR reaction (PCR 3: primers P1 and P4,
products of PCR 1 and 2 as template).
Note: Phusion polymerase (NEB) was used for the PCR reactions
(cycling parameters: 98C 30 s, 60C 45 s, 72C 1 min [30 cycles]).
Primers P2 and P3 were designed so that 20 bases would be com-
plementary to each other. To improve PCR amplification, all
primers should be designed within a similar Tm range (see
Supplemental Experimental Procedures for information regarding
primer design).
The fusion PCR product, TF-ERT2, was then cloned into a replica-
tion-incompetent Moloney murine leukemia virus construct,
pCAG-IRES-GFP (mCherry or CFP). The vector was digested with
BamHI restriction enzymes (NEB), blunted with Klenow poly-
merase (NEB), dephosphorylated with alkaline-phosphatase
(Roche), and ligated with the fusion PCR product using T4 DNA
ligase (Roche). Positive clones were evaluated by NheI restriction
digest and their sequence was confirmed by DNA sequencing.
The product of these reactions was the retroviral vector
pCAG-TF-ERT2-IRES-GFP (mCherry or CFP).
Virus Production
Viruses were produced as previously described (Zhao et al., 2006).
In brief, ten 10 cm plates of confluent human embryonic kidney
(HEK293T) cells were transfected with retroviral constructs and
packaging plasmids (pCMV-vsvg and pCMV-gp) using Lipo-
fectamine 2000 (Invitrogen). Two days after transfection, the virus
containing cell culture media (100 mL) was collected, filtered with
a 0.22 mm Steritop filter (Millipore), and centrifuged at 19,400 rpm
in an ultracentrifuge for 2 hr at 4C. The viral pellet was resus-
pended in 4 ml PBS and centrifuged a second time through a
20% sucrose cushion at 19,400 rpm for 2 hr at 4C. The final viral
pellet was resuspended in 40 ml of PBS and used for subsequent
infections.
Cell Culture
Wild-type mouse DG NSPCs (WT mDG NSPCs) were isolated as
previously described (Bracko et al., 2012). The resulting single-
cell suspension was cultured as a sphere culture in Dulbecco’s
modified Eagle’s medium (DMEM)/F12 medium supplemented
with B27 (Invitrogen), human epidermal growth factor
(20 ng/ml), and human basic fibroblast growth factor 2
(20 ng/ml; Peprotech). The medium contained an antibiotic/
antimycotic (Anti-Anti; Invitrogen). Cells were then plated on
glass coverslips coated with poly-L-ornithine (Sigma) and laminin
(Invitrogen), and heparin (5 mg/mL) was added to the medium to
obtain adherent cultures. All experiments were done in triplicates.
To analyze the efficacy of the TF-ERT2 system in vitro, WT mDG
NSPCs were infected with Ascl1-ERT2-IRES-GFP retrovirus,
NeuroD1-ERT2-IRES-GFP retrovirus, or CAG-IRES-GFP retrovirus as
a control. They were expanded for 24 hr for acute experiments
and passaged for several weeks for passaged cell experiments.
Differentiation was induced by growth factor withdrawal in the
presence and absence of hydroxy-TAM (OH-TAM; 0.5 mM). OH-
TAM was present in the differentiating medium for 2 days or a
maximum of 4 days. The medium was changed every 2–3 days.
Cells were fixed 7 days after the onset of differentiation or exposed
to OH-TAM for 4 days and further differentiated for an additional
4 days. NSPC proliferation was measured using a 1 hr pulse with
EdU (10 mM; Sigma) at 37C followed by paraformaldehyde (PFA)
fixation. EdU stainings were performed before antibody incuba-
tion using the Click-iT EdU Imaging Kit (Invitrogen) according
to the manufacturer’s protocol.
Animals
All animal experiments were approved by the veterinary office of
the Canton of Zurich, Switzerland.Mice were kept with littermates
under a 12hr dark/light cycle in single ventilated cages andwith ad
libitum access to food and water. Virus injections were performed
as previously described (Knobloch et al., 2013). To test Ascl1-ERT2-
expressing retroviruses in vivo, 6- to 8-week-old WT mice were
stereotactically injected in the DG with 1.5 ml Ascl1-ERT2-IRES-
GFP-expressing retroviruses (Karalay et al., 2011). In the first set
of experiments, the day after retrovirus injection, animals received
the first of five consecutive daily i.p. injections of TAMdissolved in
sunflower oil (100 mg/kg, both reagents from Sigma). As a control,
animals injected with the retroviruses did not receive TAM
injections. The animalswere killed 3weeks after the last TAM injec-
tion (n = 4 for each condition). In the second set of experiments,
mice were injected with Ascl1-ERT2-IRES-GFP-expressing retrovi-
ruses and red fluorescent protein (RFP)-expressing retroviruses
(Vadodaria et al., 2013) as a control. These mice received 5 daily
TAM injections 4 weeks after viral injections and were killed
1 week after the last TAM injection (n = 4). To test for directed
differentiation efficiency of the ERT2-based approached compared
with constitutive ASCL1 overexpression, we injected Ascl1-IRES-
GFP-expressing retroviruses into WT mice and killed the animals
3 weeks later (n = 4).
For tissue collection,mice were given a lethal dose of Esconarkon
(Streuli) and flushed transcardially with 0.9% sterile NaCl,
followed by fixation with 4% PFA/0.1 M phosphate buffer,
pH 7.4. The brains were postfixed in 4% PFA/0.1 M phosphate
buffer overnight at 4C, followed by 30% sucrose/0.1Mphosphate
buffer, and stored at 4C.
Immunohistochemistry
We cut the brains into 40-mm-thick free-floating sections by snap-
freezing themwith dry ice aftermounting them on amicrotome as
described previously (Karalay et al., 2011). For blocking, we used
13 TBS containing 3% donkey serum and 0.25% Triton X-100
for 30 min. Primary antibody incubation was done overnight at
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4C in the concentrations specified below. Secondary antibodies
(Jackson ImmunoResearch) were applied at 1:250 at room
temperature for 1 hr. Cell nuclei were counterstained with DAPI
(1:5,000; Sigma). For cell stainings, immunocytochemistry was
performed as described above on cells fixed with 4% PFA for
15 min at 37C. The antibodies used were chicken a-GFP (1:500;
Aves), mouse a-MAP2AB (1:500; Sigma), rabbit a-GFAP (1:500;
Dako), goat a-SOX2 (1:250; Santa Cruz), mouse a-NEUN (1:200;
Millipore), rabbit a-OLIG2 (1:250; Millipore), rabbit a-NG2
(1:500; Millipore), goat a-SOX10 (1:100; Santa Cruz), goat
a-NEUROD1 (1:250; Santa Cruz), and rabbit a-DsRed/RFP
(Clontech; 1:500).
Luciferase Assays
We electroporated Ascl1-ERT2-expressing NSPCs with pE3x6
Luciferase (Castro et al., 2006) and pTk Renilla constructs using a
nucleofector device (Amaxa). The NSPCs were then treated with
OH-TAM for 0, 5, 10, and 24 hr. The cells were then lysed in PLB
lysis buffer (Promega). We determined Luciferase and Renilla
activity using the Dual Luciferase reporter assay (Promega).
Luminescence was measured with a Novostar plate reader.
Transcriptional activity was determined as the ratio of Luciferase
activity over Renilla activity.
Image Analysis
For colocalization experiments and cell quantifications, we
performed confocal microscopy (AOBS-SP2; Leica) followed by
colocalization analyses using ImageJ with the Cell Counter plugin.
Photoshop (CS5) was used for contrast enhancements and color
adjustments.
Western Blot
HEK293T cells were transfected with retroviral constructs ex-
pressing Ascl1, Ascl1-ERT2, NeuroD1, or NeuroD1-ERT2 using
Lipofectamine (Invitrogen). Cells were lysed and extracted protein
concentrations were determined by Bradford assay (BioRad).
Proteins were separated by SDS-PAGE electrophoresis, transferred
to a nitrocellulose membrane (BioRad), and probed with primary
antibodies, goat a-NEUROD1 (1:1,000; Santa Cruz), mouse
a-ASCL1 (1:1,000; BD), mouse a-GAPDH (1:10,000; HyTest), and
rabbit a-MATRIN3 (1:2,000; Bethyl) followed by horseradish-
peroxidase-conjugated secondary antibodies (Jackson Immuno-
Research), and bands were detected by chemiluminescence
(Thermo Scientific).
Fractionation of Cytoplasmic and Nuclear Proteins
Fractionations were performed as previously described
(Knobloch et al., 2013). Ascl1-ERT2-expressing NSPCs were lysed
in 0.5% Triton buffer. Lysates were centrifuged at 13 krpm for
15 min at 4C to separate insoluble nuclei. The supernatant con-
taining the membrane proteins was removed and stored on ice.
The nuclear pellet was rinsed twice with lysis buffer and then
resuspended in lysis buffer containing 0.5% SDS and sonicated.
The samples were precleared by centrifugation at 13 krpm for
15min at 4C and the supernatant containing the nuclear proteins
was stored on ice. The samples were then used for western blot
analysis.
Statistical Analyses
Statistical analyses were performed using Excel (Microsoft). Two
sample t tests were used for all comparisons. Differences were
considered significant at p < 0.001.
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